Stopping lenalidomide after two years may give you the same survival as taking it forever — with fewer side effects and lower cancer risk.

The study linked in the post found that after seven years, the number of people still alive was nearly identical whether they stopped lenalidomide after two years or kept taking it for life. Other research shows that long-term use of the drug is linked to a higher chance of dangerous blood cell changes and new cancers, and those risks tend to drop when people stop taking it. This suggests that stopping early might avoid extra harm without losing survival benefits — a meaningful trade-off for people managing a chronic illness.